Ramon Camps-Ubach

Dr. Ramon Camps-Ubach

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CCCarme Casadevall
Carme Casadevall
BABella Agranovich
Bella Agranovich
César Jessé Enríquez-RodríguezCésar Jessé Enríquez-Rodríguez
César Jessé Enríquez-Rodríguez
RFRosa Faner
Rosa Faner
SPSergi Pascual-Guàrdia
Sergi Pascual-Guàrdia
Joaquim GeaJoaquim Gea
Joaquim Gea
The analysis of blood metabolites may help identify individuals at risk of having COPD and offer insights into its underlying pathophysiology. This study aimed to identify COPD-related metabolic alterations and generate a biological signature potentially useful for screening purposes. Plasma metabolomic profiles from 91 COPD patients and 91 controls were obtained using complementary semi-targeted and untargeted LC-MS approaches. Univariate analysis identified metabolites with significant differences between groups, and enrichment analysis highlighted the most affected metabolic pathways. Multivariate analysis, including ROC curve assessment and machine learning algorithms, was applied to assess the discriminatory capacity of selected metabolites. After adjustment for major potential confounders, 56 metabolites showed significant differences between COPD patients and controls. The enrichment analysis revealed that COPD-associated metabolic alterations primarily involved lipid metabolism (especially fatty acids and acylcarnitines), followed by amino acid pathways and xenobiotics. A panel of 10 metabolites, mostly related to lipid metabolism, demonstrated high discriminatory performance for COPD (ROC-AUC: 0.916; 90.1% sensitivity and 89% specificity). These findings may contribute to improving screening strategies and a better understanding of COPD-related metabolic changes. However, our findings remain exploratory and should be interpreted with caution, needing further validation and mechanistic studies.

4 November 2025 in Cells
Verified
Journal Article
Open access
PDF file
Joaquim GeaJoaquim Gea
Joaquim Gea
MOMauricio Orozco-Levi
Mauricio Orozco-Levi
SPSergi Pascual-Guàrdia
Sergi Pascual-Guàrdia
CCCarme Casadevall
Carme Casadevall
César Jessé Enríquez-RodríguezCésar Jessé Enríquez-Rodríguez
César Jessé Enríquez-Rodríguez
ESTHER BARREIROESTHER BARREIRO
ESTHER BARREIRO
Skeletal muscle dysfunction is a major systemic manifestation of COPD that shapes symptoms, exercise tolerance and mortality. Current evidence can be integrated within a Damage–Regeneration–Remodeling framework linking mechanics and biology to clinical phenotypes. Pulmonary hyperinflation and chest wall geometry chronically load the diaphragm and other respiratory muscles in COPD, whereas inactivity and exacerbation-related disuse underload locomotor muscles. Across muscle compartments, oxidative/nitrosative stress, activation of proteolytic pathways, mitochondrial and endoplasmic reticulum stress, microvascular limitations, neuromuscular junction instability, and myosteatosis degrade muscle quality. The diaphragm adapts with a fast-to-slow fiber shift, greater oxidative capacity, and sarcomere foreshortening, improving endurance, whereas limb muscles show atrophy, a glycolytic shift, reduced oxidative enzymes, extracellular matrix accrual, and fat infiltration. Translational levers that address these mechanisms include: (I) Reduce damage: bronchodilation, lung-volume reduction, oxygen, non-invasive ventilation, early mobilization, pulmonary rehabilitation, neuromuscular stimulation, and corticosteroid stewardship; (II) Enable regeneration: progressive resistance plus high-intensity/heavy-load endurance training; adequate protein and vitamin-D intake, and endocrine correction; and (III) Steer remodeling: increase physical activity (with/without coaching/telecoaching), functional assessment and CT or MRI monitoring, inspiratory-muscle training, and phenotype-guided adjuncts in selected cases. This framework clarifies why lung deflation strategies benefit inspiratory mechanics, whereas limb recovery requires behavioral and metabolic interventions layered onto systemic optimization.

7 March 2026 in Metabolites
Verified
Journal Article
Open access
PDF file
CCCarme Casadevall
Carme Casadevall
César Jessé Enríquez-RodríguezCésar Jessé Enríquez-Rodríguez
César Jessé Enríquez-Rodríguez
AEAlexandra Eliassaf
Alexandra Eliassaf
Ady Angélica Castro-AcostaAdy Angélica Castro-Acosta
Ady Angélica Castro-Acosta
RFRosa Faner
Rosa Faner
OGon behalf of the BIOMEPOC group
on behalf of the BIOMEPOC group
Metabolomic studies in COPD reveal systemic metabolic perturbations, yet sex is often treated as a covariate rather than a biological driver. We aimed to identify plasma metabolites differentiating COPD from controls and to define sex-specific metabolic signatures in both groups. Methods: In this controlled observational study (BIOMEPOC cohort), untargeted plasma metabolomics was performed by LC-MS/MS. Differential abundance was tested across four contrasts (COPD vs. controls; men vs. women within controls; men vs. women within COPD; sex-by-disease interaction) with a false discovery rate (FDR) correction. Because smoking history differed between COPD and controls, a post hoc ever-smokers analysis was conducted. Results: COPD differed from controls in nine metabolites (all decreased): DL-stachydrine, 3-methyl-L-histidine, fructose, pipecolinic and nipecotic acids, 5-nitro-o-toluidine, conjugated linoleic acid, aminoadipate, and creatinine. This pattern is compatible with metabolic depletion, remodeling, and/or altered flux across multiple compartments rather than simple substrate deficiency, spanning muscle-related pools, amino acid handling, carbohydrate-associated metabolism, and exposome-linked inputs. In ever-smokers, results were directionally consistent, with five metabolites remaining nominally significant. Among controls, five metabolites were higher in men after FDR correction (PABA, cis-4-hydroxy-D-proline, N-acetylasparagine, deoxycarnitine, and creatinine), consistent with physiological sex dimorphism in energy pathways, connective-tissue remodeling, and diet/microbiome-related metabolism. Within COPD, six metabolites differed by sex after FDR correction, defining three axes: creatine energy buffering (men: higher GAA/creatinine, lower creatine), purine/urate handling (men: higher urate), and conjugated bile acids (men: higher GCDCA), implicating muscle bioenergetics, redox/inflammatory tone, and gut–liver crosstalk. Conclusions: Plasma metabolomics identifies a pattern compatible with systemic remodeling in COPD and sex-associated divergences in creatine, purine/urate, and bile-acid pathways, supporting a sex-influenced view of systemic COPD heterogeneity and highlighting targets for mechanistic validation.

Verified
Journal Article
Open access
PDF file
César Jessé Enríquez-RodríguezCésar Jessé Enríquez-Rodríguez
César Jessé Enríquez-Rodríguez
BABella Agranovich
Bella Agranovich
SPSergi Pascual-Guàrdia
Sergi Pascual-Guàrdia
RFRosa Faner
Rosa Faner
RCRamon Camps-Ubach
Ramon Camps-Ubach
OGon behalf of the BIOMEPOC Group
on behalf of the BIOMEPOC Group
Chronic Obstructive Pulmonary Disease (COPD) is a complex condition with high mortality. Early identification of patients at increased risk of death remains a major clinical challenge. This pilot study aimed to explore whether plasma metabolomic profiling could aid in the prediction of long-term (7-year) mortality and provide insight into potential underlying mechanisms. Plasma samples from 54 randomly selected stable COPD patients were analyzed using both untargeted and semi-targeted LC-MS approaches. After excluding patients with unclear death data, non-COPD-related deaths and metabolomic outliers, 41 individuals were included in the final analysis. During follow-up, 13 patients (32%) died, and 28 survived. Univariate analysis identified 12 metabolites—mainly amino acids—that differed significantly between the two groups. Functional analysis suggested a significant disruption in energy production pathways. Predictive models developed using machine learning algorithms, consisting of either ten metabolites alone or nine metabolites plus FEV1, achieved high accuracy for 7-year mortality prediction, with the latter model performing slightly better. Internal validation was conducted using five-fold cross-validation. While exploratory, these findings support the hypothesis that early metabolic alterations, particularly in energy pathways, may contribute to long-term mortality risk in stable COPD patients, and could complement traditional prognostic markers such as FEV1.

Verified
Journal Article
Open access
PDF file
César Jessé Enríquez-RodríguezCésar Jessé Enríquez-Rodríguez
César Jessé Enríquez-Rodríguez
BABella Agranovich
Bella Agranovich
SPSergi Pascual-Guàrdia
Sergi Pascual-Guàrdia
RFRosa Faner
Rosa Faner
RCRamon Camps-Ubach
Ramon Camps-Ubach
OGon behalf of the BIOMEPOC Group
on behalf of the BIOMEPOC Group
In the original publication, the authors identified a mistake in Table 4 as published

4 June 2026 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
ACAna Balañá Corberó
Ana Balañá Corberó
ACArnau Pons Calsapeu
Arnau Pons Calsapeu
FSFrancesc López Seguí
Francesc López Seguí
RCRamon Camps-Ubach
Ramon Camps-Ubach
JLJuana Martínez Llorens
Juana Martínez Llorens
Telemonitoring combined with synchronous video consultation is an increasingly used strat-egy in the management of patients on home mechanical ventilation (HMV). The aim of this study was to evaluate ventilation parameters and healthcare resource utilization in a tele-monitoring program (TG) compared to usual care (UG). A retrospective comparative study was conducted, comparing HMV patients assigned to telematic follow-up with a historical cohort receiving standard in-person follow-up. Ventilation parameters included apnea-hypopnea index (AHI), average daily use (h/day), and mean leak (L/min). Efficiency was as-sessed by the total number of hospital visits and in-person hospital visits. Average daily use (8.3±2.9 h/day vs. 8.5±3.4 h/day; p=0.714) and mean leak (6.4±11.9 L/min vs. 6.3±9.6 L/min; p=0.701) did not differ significantly between groups. The TG showed a lower AHI compared with the UG [4.1±5.0/hour vs. 7.9±12.2/hour; respectively (p=0.008)]. The TG was also associated with fewer annual total visits (3.5±2.4 vs. 6.9±5.0; p<0.001) and fewer annual in-person visits (2.1±1.6 vs. 6.9±5.0; p<0.001). Kaplan-Meier curves were used for descriptive purposes. In multivariable Cox regression adjusted for age category, diagnostic group, baseline arterial blood carbon dioxide pressure, and sex, the TG was associated with a lower hazard of death (0.51; 95% confidence interval 0.24-1.09; p=0.08). These findings indicate that telemonitoring combined with synchronous video consultation was associated with better ventilatory control (lower AHI) and lower use of in-person healthcare visits, with-out evidence of impaired adherence or safety.